Previous Article | Next Article 
Journal of Virology, April 2003, p. 4827-4835, Vol. 77, No. 8
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.8.4827-4835.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155
Yongning He,1 Steffen Mueller,2 Paul R. Chipman,1 Carol M. Bator,1 Xiaozhong Peng,2 Valorie D. Bowman,1 Suchetana Mukhopadhyay,1 Eckard Wimmer,2 Richard J. Kuhn,1 and Michael G. Rossmann1*
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907,1
Department of Molecular Genetics and Microbiology, School of Medicine Health Sciences Center, State University of New York, Stony Brook, New York 117942
Received 30 October 2002/
Accepted 21 January 2003
Structures of all three poliovirus (PV) serotypes (PV1, PV2, and PV3) complexed with their cellular receptor, PV receptor (PVR or CD155), were determined by cryoelectron microscopy. Both glycosylated and fully deglycosylated CD155 exhibited similar binding sites and orientations in the viral canyon for all three PV serotypes, showing that all three serotypes use a common mechanism for cell entry. Difference maps between the glycosylated and deglycosylated CD155 complexes determined the sites of the carbohydrate moieties that, in turn, helped to verify the position of the receptor relative to the viral surface. The proximity of the CD155 carbohydrate site at Asn105 to the viral surface in the receptor-virus complex suggests that it might interfere with receptor docking, an observation consistent with the properties of mutant CD155. The footprints of CD155 on PV surfaces indicate that the south rim of the canyon dominates the virus-receptor interactions and may correspond to the initial CD155 binding state of the receptor-mediated viral uncoating. In contrast, the interaction of CD155 with the north rim of the canyon, especially the region immediately outside the viral hydrophobic pocket that normally binds a cellular "pocket factor," may be critical for the release of the pocket factor, decreasing the virus stability and hence initiating uncoating. The large area of the CD155 footprint on the PV surface, in comparison with other picornavirus-receptor interactions, could be a potential limitation on the viability of PV escape mutants from antibody neutralization. Many of these are likely to have lost their ability to bind CD155, resulting in there being only three PV serotypes.
* Corresponding author. Mailing address: Department of Biological Sciences, Purdue University, Lilly Hall, 915 W. State St., West Lafayette, IN 47907-2054. Phone: (765) 494-4911. Fax: (765) 496-1189. E-mail:
mgr{at}indiana.bio.purdue.edu.
Journal of Virology, April 2003, p. 4827-4835, Vol. 77, No. 8
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.8.4827-4835.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
van der Sanden, S., Pallansch, M. A., van de Kassteele, J., El-Sayed, N., Sutter, R. W., Koopmans, M., van der Avoort, H.
(2009). Shedding of Vaccine Viruses with Increased Antigenic and Genetic Divergence after Vaccination of Newborns with Monovalent Type 1 Oral Poliovirus Vaccine. J. Virol.
83: 8693-8704
[Abstract]
[Full Text]
-
Zhang, P., Mueller, S., Morais, M. C., Bator, C. M., Bowman, V. D., Hafenstein, S., Wimmer, E., Rossmann, M. G.
(2008). Crystal structure of CD155 and electron microscopic studies of its complexes with polioviruses. Proc. Natl. Acad. Sci. USA
105: 18284-18289
[Abstract]
[Full Text]
-
Khan, S., Peng, X., Yin, J., Zhang, P., Wimmer, E.
(2008). Characterization of the New World Monkey Homologues of Human Poliovirus Receptor CD155. J. Virol.
82: 7167-7179
[Abstract]
[Full Text]
-
Dedepsidis, E., Kyriakopoulou, Z., Pliaka, V., Kottaridi, C., Bolanaki, E., Levidiotou-Stefanou, S., Komiotis, D., Markoulatos, P.
(2007). Retrospective Characterization of a Vaccine-Derived Poliovirus Type 1 Isolate from Sewage in Greece. Appl. Environ. Microbiol.
73: 6697-6704
[Abstract]
[Full Text]
-
Kim, M. S., Racaniello, V. R.
(2007). Enterovirus 70 Receptor Utilization Is Controlled by Capsid Residues That Also Regulate Host Range and Cytopathogenicity. J. Virol.
81: 8648-8655
[Abstract]
[Full Text]
-
Yakovenko, M. L., Cherkasova, E. A., Rezapkin, G. V., Ivanova, O. E., Ivanov, A. P., Eremeeva, T. P., Baykova, O. Y., Chumakov, K. M., Agol, V. I.
(2006). Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties. J. Virol.
80: 2641-2653
[Abstract]
[Full Text]
-
Pettigrew, D. M., Williams, D. T., Kerrigan, D., Evans, D. J., Lea, S. M., Bhella, D.
(2006). Structural and Functional Insights into the Interaction of Echoviruses and Decay-accelerating Factor. J. Biol. Chem.
281: 5169-5177
[Abstract]
[Full Text]
-
Tuthill, T. J., Bubeck, D., Rowlands, D. J., Hogle, J. M.
(2006). Characterization of Early Steps in the Poliovirus Infection Process: Receptor-Decorated Liposomes Induce Conversion of the Virus to Membrane-Anchored Entry-Intermediate Particles. J. Virol.
80: 172-180
[Abstract]
[Full Text]
-
Milstone, A. M., Petrella, J., Sanchez, M. D., Mahmud, M., Whitbeck, J. C., Bergelson, J. M.
(2005). Interaction with Coxsackievirus and Adenovirus Receptor, but Not with Decay-Accelerating Factor (DAF), Induces A-Particle Formation in a DAF-Binding Coxsackievirus B3 Isolate. J. Virol.
79: 655-660
[Abstract]
[Full Text]
-
Johansson, E. S., Xing, L., Cheng, R. H., Shafren, D. R.
(2004). Enhanced Cellular Receptor Usage by a Bioselected Variant of Coxsackievirus A21. J. Virol.
78: 12603-12612
[Abstract]
[Full Text]
-
Duque, H., LaRocco, M., Golde, W. T., Baxt, B.
(2004). Interactions of Foot-and-Mouth Disease Virus with Soluble Bovine {alpha}V{beta}3 and {alpha}V{beta}6 Integrins. J. Virol.
78: 9773-9781
[Abstract]
[Full Text]
-
Bhella, D., Goodfellow, I. G., Roversi, P., Pettigrew, D., Chaudhry, Y., Evans, D. J., Lea, S. M.
(2004). The Structure of Echovirus Type 12 Bound to a Two-domain Fragment of Its Cellular Attachment Protein Decay-accelerating Factor (CD 55). J. Biol. Chem.
279: 8325-8332
[Abstract]
[Full Text]